Amedisys Valuation
| AMED Stock | USD 92.64 0.07 0.08% |
At this time, the firm appears to be undervalued. Amedisys shows a prevailing Real Value of $101.8 per share. The current price of the firm is $92.64. Our model approximates the value of Amedisys from analyzing the firm fundamentals such as profit margin of 0.02 %, and Return On Equity of 0.0332 as well as examining its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Amedisys' valuation include:
Price Book 2.6771 | Enterprise Value | Enterprise Value Ebitda 17.9964 | Price Sales 1.2934 | Forward PE 18.7266 |
Undervalued
Today
Please note that Amedisys' price fluctuation is very steady at this time. Calculation of the real value of Amedisys is based on 3 months time horizon. Increasing Amedisys' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Amedisys stock is determined by what a typical buyer is willing to pay for full or partial control of Amedisys. Since Amedisys is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Amedisys Stock. However, Amedisys' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 92.64 | Real 101.8 | Target 96.86 | Hype 92.65 |
The real value of Amedisys Stock, also known as its intrinsic value, is the underlying worth of Amedisys Company, which is reflected in its stock price. It is based on Amedisys' financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Amedisys' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Amedisys helps investors to forecast how Amedisys stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Amedisys more accurately as focusing exclusively on Amedisys' fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Amedisys' intrinsic value based on its ongoing forecasts of Amedisys' financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Amedisys' closest peers. If more than one evaluation category is relevant for Amedisys we suggest using both methods to arrive at a better estimate.
Amedisys Cash |
|
Amedisys Valuation Trend
Comparing Amedisys' enterprise value against its market capitalization is a good way to estimate the value of Amedisys uage its performance over time. This information may sometimes be enough for investors to make reasonable market timing decisions.
Amedisys Revenue by Product
Amedisys Total Value Analysis
Amedisys is presently forecasted to have valuation of 3.19 B with market capitalization of 3.04 B, debt of 460.18 M, and cash on hands of 17.96 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Amedisys fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
3.19 B | 3.04 B | 460.18 M | 17.96 M |
Amedisys Investor Information
About 91.0% of the company shares are held by institutions such as insurance companies. The book value of Amedisys was presently reported as 34.62. The company has Price/Earnings To Growth (PEG) ratio of 1.25. Amedisys had not issued any dividends in recent years. The entity had 4:3 split on the 5th of December 2006. Based on the key indicators related to Amedisys' liquidity, profitability, solvency, and operating efficiency, Amedisys may be sliding down financialy. It has an above-average probability of going through some form of financial hardship next quarter.Amedisys Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Amedisys has an asset utilization ratio of 109.8 percent. This indicates that the Company is making $1.1 for each dollar of assets. An increasing asset utilization means that Amedisys is more efficient with each dollar of assets it utilizes for everyday operations.Amedisys Ownership Allocation
Amedisys holds a total of 32.81 Million outstanding shares. The majority of Amedisys outstanding shares are owned by other corporate entities. These outside corporations are usually referred to as non-private investors looking to acquire positions in Amedisys to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in Amedisys. Please pay attention to any change in the institutional holdings of Amedisys as this could imply that something significant has changed or is about to change at the company. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.Amedisys Profitability Analysis
The company reported the previous year's revenue of 2.35 B. Net Income was 38.16 M with profit before overhead, payroll, taxes, and interest of 1.02 B.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Amedisys' worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Amedisys and how it compares across the competition.
About Amedisys Valuation
The stock valuation mechanism determines Amedisys' current worth on a weekly basis. Our valuation model uses a comparative analysis of Amedisys. We calculate exposure to Amedisys's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Amedisys's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 1 B | 1.1 B | |
| Pretax Profit Margin | 0.04 | 0.04 | |
| Operating Profit Margin | 0.04 | 0.04 | |
| Net Profit Margin | 0.02 | 0.02 | |
| Gross Profit Margin | 0.43 | 0.52 |
Amedisys Growth Indicators
Investing in growth stocks can be very risky. If the company such as Amedisys does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 33.1 M | |
| Quarterly Earnings Growth Y O Y | -0.354 | |
| Forward Price Earnings | 18.7266 |
Amedisys Current Valuation Indicators
Valuation refers to the process of determining the present value of Amedisys and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value Amedisys we look at many different elements of the entity such as Amedisys's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Amedisys, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Amedisys' valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Amedisys' worth.Complementary Tools for Amedisys Stock analysis
When running Amedisys' price analysis, check to measure Amedisys' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Amedisys is operating at the current time. Most of Amedisys' value examination focuses on studying past and present price action to predict the probability of Amedisys' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Amedisys' price. Additionally, you may evaluate how the addition of Amedisys to your portfolios can decrease your overall portfolio volatility.
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments |